Patents by Inventor Mark Carl Noe

Mark Carl Noe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Protecting RNA
    Publication number: 20240122865
    Abstract: The present disclosure provides methods of protecting ribonucleic acid (RNA) from degradation under certain conditions by contacting the RNA with an amino acid. The present disclosure also provides compositions comprising such amino acid(s) and RNA.
    Type: Application
    Filed: February 15, 2022
    Publication date: April 18, 2024
    Applicant: Pfizer Inc.
    Inventors: Justin Leigh Bellenger, Ye Che, Miguel Angel Garcia, Lei Hu, Mark Carl Noe, Shuai Shi
  • MACROLIDES
    Publication number: 20080293646
    Abstract: The invention relates to compounds of Formula (I): wherein R1, R2 and X are as defined herein. The invention also relates to pharmaceutical compositions and methods of treating bacterial infections using compounds of Formula (I).
    Type: Application
    Filed: March 12, 2008
    Publication date: November 27, 2008
    Inventors: Thomas V. Magee, Usa Reilly, Mark Carl Noe, Mark E. Flanagan, Zhengong Bryan Li, Richard Allen Buzon, Daniel William Widlicka
  • Heterocyclic derivatives useful as anticancer agents
    Patent number: 6380214
    Abstract: The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein Z, X, X1, R1, R2 and R3 are as defined herein as it relates to pharmaceutical compositions containing the above compounds for the treatment of disorders mediated by angiogenesis in mammals by administration of the above compounds.
    Type: Grant
    Filed: April 17, 2000
    Date of Patent: April 30, 2002
    Assignee: Pfizer Inc.
    Inventors: Thomas George Gant, Mark Carl Noe